BTS
CASC

BB&T Securities’s Cascadian Therapeutics, Inc. CASC Stock Holding History

BB&T Securities’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-48,999
Closed -$181K – 1564
2017
Q4 		$181K Sell
48,999
-833
-2% -$3.08K ﹤0.01% 1354
2017
Q3 		$203K Buy
49,832
+11,118
+29% +$45.3K ﹤0.01% 1276
2017
Q2 		$143K Buy
+38,714
New +$143K ﹤0.01% 1313